Glucose-6-phosphate Transporter Gene Therapy Corrects Metabolic and Myeloid Abnormalities in Glycogen Storage Disease Type Ib Mice

Overview

Journal Gene Ther

Date 2006 Sep 29

PMID 17006547

Citations 20

Authors

W H Yiu

C-J Pan

M Allamarvdasht

S Y Kim

J Y Chou

Affiliations

Soon will be listed here.

Abstract

Glycogen storage disease type Ib (GSD-Ib) is caused by a deficiency in the glucose-6-phosphate transporter (G6PT), an endoplasmic reticulum-associated transmembrane protein that is ubiquitously expressed. GSD-Ib patients suffer from disturbed glucose homeostasis and myeloid dysfunctions. To evaluate the feasibility of gene replacement therapy for GSD-Ib, we have infused adenoviral (Ad) vector containing human G6PT (Ad-hG6PT) into G6PT-deficient (G6PT(-/-)) mice that manifest symptoms characteristics of the human disorder. Ad-hG6PT infusion restores significant levels of G6PT mRNA expression in the liver, bone marrow and spleen, and corrects metabolic as well as myeloid abnormalities in G6PT(-/-) mice. The G6PT(-/-) mice receiving gene therapy exhibit improved growth; normalized serum profiles for glucose, cholesterol, triglyceride, uric acid and lactic acid; and reduced hepatic glycogen deposition. The therapy also corrects neutropenia and lowers the elevated serum levels of granulocyte colony-stimulating factor. The development of bone and spleen in the infused G6PT(-/-) mice is improved and accompanied by increased cellularity and normalized myeloid progenitor cell frequencies in both tissues. This effective use of gene therapy to correct metabolic imbalances and myeloid dysfunctions in GSD-Ib mice holds promise for the future of gene therapy in humans.

Citing Articles

Metabolism: a potential regulator of neutrophil fate.

Yipeng Z, Chao C, Ranran L, Tingting P, Hongping Q Front Immunol. 2024; 15():1500676.

PMID: 39697327 PMC: 11652355. DOI: 10.3389/fimmu.2024.1500676.

Glycogen storage disease type I: Genetic etiology, clinical manifestations, and conventional and gene therapies.

Zhong J, Gou Y, Zhao P, Dong X, Guo M, Li A Pediatr Discov. 2024; 1(2).

PMID: 38370424 PMC: 10874634. DOI: 10.1002/pdi3.3.

Glycogen storage diseases: An update.

Gumus E, Ozen H World J Gastroenterol. 2023; 29(25):3932-3963.

PMID: 37476587 PMC: 10354582. DOI: 10.3748/wjg.v29.i25.3932.

Gene therapy for glycogen storage diseases.

Koeberl D, Koch R, Lim J, Brooks E, Arnson B, Sun B J Inherit Metab Dis. 2023; 47(1):93-118.

PMID: 37421310 PMC: 10874648. DOI: 10.1002/jimd.12654.

Preclinical Research in Glycogen Storage Diseases: A Comprehensive Review of Current Animal Models.

Almodovar-Paya A, Villarreal-Salazar M, De Luna N, Nogales-Gadea G, Real-Martinez A, Andreu A Int J Mol Sci. 2020; 21(24).

PMID: 33348688 PMC: 7766110. DOI: 10.3390/ijms21249621.

References

Matern D, Starzl T, Arnaout W, Barnard J, Bynon J, Dhawan A . Liver transplantation for glycogen storage disease types I, III, and IV. Eur J Pediatr. 1999; 158 Suppl 2:S43-8. PMC: 3006437. DOI: 10.1007/pl00014320. View

Lei K, Chen H, Pan C, Ward J, Mosinger Jr B, Lee E . Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse. Nat Genet. 1996; 13(2):203-9. DOI: 10.1038/ng0696-203. View

Wilson J . Adenovirus-mediated gene transfer to liver. Adv Drug Deliv Rev. 2001; 46(1-3):205-9. DOI: 10.1016/s0169-409x(00)00125-3. View

Garty B, Douglas S, Danon Y . Immune deficiency in glycogen storage disease type 1B. Isr J Med Sci. 1996; 32(12):1276-81. View

Pan C, Lei K, Chen H, Ward J, Chou J . Ontogeny of the murine glucose-6-phosphatase system. Arch Biochem Biophys. 1998; 358(1):17-24. DOI: 10.1006/abbi.1998.0849. View

Lin B, Annabi B, Hiraiwa H, Pan C, Chou J . Cloning and characterization of cDNAs encoding a candidate glycogen storage disease type 1b protein in rodents. J Biol Chem. 1998; 273(48):31656-60. DOI: 10.1074/jbc.273.48.31656. View

Hiraiwa H, Pan C, Lin B, Moses S, Chou J . Inactivation of the glucose 6-phosphate transporter causes glycogen storage disease type 1b. J Biol Chem. 1999; 274(9):5532-6. DOI: 10.1074/jbc.274.9.5532. View

Pan C, Lin B, Chou J . Transmembrane topology of human glucose 6-phosphate transporter. J Biol Chem. 1999; 274(20):13865-9. DOI: 10.1074/jbc.274.20.13865. View

Benihoud K, Yeh P, Perricaudet M . Adenovirus vectors for gene delivery. Curr Opin Biotechnol. 1999; 10(5):440-7. DOI: 10.1016/s0958-1669(99)00007-5. View

10.

Palmer D, Ng P . Helper-dependent adenoviral vectors for gene therapy. Hum Gene Ther. 2005; 16(1):1-16. DOI: 10.1089/hum.2005.16.1. View

11.

Alba R, Bosch A, Chillon M . Gutless adenovirus: last-generation adenovirus for gene therapy. Gene Ther. 2005; 12 Suppl 1:S18-27. DOI: 10.1038/sj.gt.3302612. View

12.

Zhong L, Li W, Li Y, Zhao W, Wu J, Li B . Evaluation of primitive murine hematopoietic stem and progenitor cell transduction in vitro and in vivo by recombinant adeno-associated virus vector serotypes 1 through 5. Hum Gene Ther. 2006; 17(3):321-33. DOI: 10.1089/hum.2006.17.321. View

13.

Lopez-Sanroman A, Martin-Vaquero P, Molina-Perez E, Barcena R, Vicente E, Candela A . Liver transplantation for type Ib glycogenosis with reversal of cyclic neutropenia. Clin Nutr. 2001; 20(4):375-7. DOI: 10.1054/clnu.2001.0432. View

14.

Chou J, Matern D, Mansfield B, Chen Y . Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex. Curr Mol Med. 2002; 2(2):121-43. DOI: 10.2174/1566524024605798. View

15.

Breyer B, Jiang W, Cheng H, Zhou L, Paul R, Feng T . Adenoviral vector-mediated gene transfer for human gene therapy. Curr Gene Ther. 2002; 1(2):149-62. DOI: 10.2174/1566523013348689. View

16.

Wolber F, Leonard E, Michael S, Yoder M, Srour E . Roles of spleen and liver in development of the murine hematopoietic system. Exp Hematol. 2002; 30(9):1010-9. DOI: 10.1016/s0301-472x(02)00881-0. View

17.

Chen L, Pan C, Shieh J, Chou J . Structure-function analysis of the glucose-6-phosphate transporter deficient in glycogen storage disease type Ib. Hum Mol Genet. 2002; 11(25):3199-207. DOI: 10.1093/hmg/11.25.3199. View

18.

Chen L, Shieh J, Lin B, Pan C, Gao J, Murphy P . Impaired glucose homeostasis, neutrophil trafficking and function in mice lacking the glucose-6-phosphate transporter. Hum Mol Genet. 2003; 12(19):2547-58. DOI: 10.1093/hmg/ddg263. View

19.

Tenenbaum L, Lehtonen E, Monahan P . Evaluation of risks related to the use of adeno-associated virus-based vectors. Curr Gene Ther. 2003; 3(6):545-65. DOI: 10.2174/1566523034578131. View

20.

Adachi M, Shinkai M, Ohhama Y, Tachibana K, Kuratsuji T, Saji H . Improved neutrophil function in a glycogen storage disease type 1b patient after liver transplantation. Eur J Pediatr. 2004; 163(4-5):202-6. DOI: 10.1007/s00431-004-1405-1. View